-
ALS patient improving with stem-cell treatments
Jeff Dore visits NSI-566/ALS Phase I patient Ted Harada, who shares his story, claiming he's "the luckiest man on the face of the earth." Site Principal Investigator, Emory's Jonathan D. Glass, MD, is also interviewed, in advance of the Phase II trial.
Select media coverage in this website is provided for the information and convenience of the public, and is not intended to be all-encompassing nor an endorsement of the specific stories or media outlets.